Novo Nordisk spends up to $1.64bn on US biotech startups
Pharmaceutical Technology
JANUARY 7, 2024
Novo Nordisk taps Flagship Pioneering portfolio companies Omega Therapeutics and Cellarity as obesity drugs competition intensifies.
Sun.Jan 07, 2024
246 
Eating Late Can Change How You Burn Calories And Store Fat, Depressing Study Shows
AuroBlog - Aurous Healthcare Clinical Trials blog
JANUARY 7, 2024
A study suggests eating later in the day can directly impact our biological weight regulation in three key ways: through the number of calories that we burn; our hunger levels; and the way our bodies store fat.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
After buying Novan's assets, Ligand crosses FDA finish line with molluscum gel Zelsuvmi
Fierce Pharma
JANUARY 7, 2024
Less than six months after Ligand Pharmaceuticals swooped in to buy Novan’s assets following the latter company’s bankruptcy, the purchase has paid off with an FDA approval. | Less than six months after Ligand Pharmaceuticals swooped in to buy Novan’s assets following the latter company’s bankruptcy, the purchase has paid off with an FDA approval.
Diagnostic Errors in Hospitalized Adults Who Died or Were Transferred to Intensive Care
JAMA Internal Medicine
JANUARY 7, 2024
This cohort study assesses the prevalence, underlying causes, and harms of diagnostic errors among hospitalized adults who died or were transferred to intensive care.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Lilly launches telehealth option for obesity and other drugs
pharmaphorum
JANUARY 7, 2024
Eli Lilly has launched a new website-based access programme for some drugs like its new obesity therapy Zepbound, opening up a new direct-to-consumer (DTC) channel that
Which pharmaceutical companies have the most drug patents in Hong Kong?
Drug Patent Watch
JANUARY 7, 2024
This chart shows the pharmaceutical companies with the most patents in Hong Kong. Patents must be filed in each country (or, in some cases regional patent office) where patent protection… The post Which pharmaceutical companies have the most drug patents in Hong Kong? appeared first on DrugPatentWatch - Make Better Decisions.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
New patent expiration for Btcp Pharma drug LAZANDA
Drug Patent Watch
JANUARY 7, 2024
Annual Drug Patent Expirations for LAZANDA Lazanda is a drug marketed by Btcp Pharma and is included in one NDA. There are five patents protecting this drug. This drug has… The post New patent expiration for Btcp Pharma drug LAZANDA appeared first on DrugPatentWatch - Make Better Decisions.
Why are Post-Approval Pregnancy Studies Post-Marking Requirements Rather Than Post-Marketing Commitments?
FDA Law Blog
JANUARY 7, 2024
By McKenzie E. Cato — New Year’s is often associated with baby New Year and with resolutions, which in a convoluted way got us thinking about post-approval pregnancy studies. Lots of us start the new year with a resolution. Is it a commitment, or a requirement, and does the difference matter? For post-approval pregnancy studies, it most certainly does.
Population-Based Trends in Complexity of Hospital Inpatients
JAMA Internal Medicine
JANUARY 7, 2024
This cohort study assesses whether there has been an increase in measures of hospital inpatient complexity in British Columbia, Canada, over a 15-year period.
Florida approved to import Canadian prescription drugs
Pharma in Brief
JANUARY 7, 2024
On January 5, 2024, the US Food and Drug Administration ( FDA ) approved Florida’s proposal to import prescription drugs from Canada. This is the first approval of a Section 804 Importation Program ( SIP ) by the FDA. Whether Florida is able to import drugs from Canada, including in light of Canadian regulations controlling drug exports, remains to be seen.
Let's personalize your content